​

Cencora (COR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

COR Stock Forecast

Cencora (COR) stock forecast, based on 39 Wall Street analysts, predicts a 12-month average price target of $288.00, with a high of $288.00 and a low of $288.00. This represents a 0.44% increase from the last price of $286.74.

$205 $222 $239 $256 $273 $290 High: $288 Avg: $288 Low: $288 Last Closed Price: $286.74

COR Stock Rating

Cencora stock's rating consensus is Buy, based on 39 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (66.67%), 13 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 39 13 26 0 Strong Sell Sell Hold Buy Strong Buy

COR Price Target Upside V Benchmarks

TypeNameUpside
StockCencora0.44%
SectorHealthcare Stocks 35.25%
IndustryMedical Distribution Stocks6.26%

Price Target Trends

1M3M12M
# Anlaysts116
Avg Price Target$288.00$288.00$277.83
Last Closing Price$286.74$286.74$286.74
Upside/Downside0.44%0.44%-3.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25196-117
Mar, 25197--17
Feb, 25196-117
Jan, 25197-118
Dec, 24287-118
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 15, 2025Erin WrightMorgan Stanley$288.00$284.541.22%0.44%
Sep 18, 2024Daniel GrosslightCitigroup$284.00$229.3423.83%-0.96%
Sep 18, 2024Allen LutzBank of America Securities$245.00$234.534.46%-14.56%
Sep 06, 2024David RodgersRobert W. Baird$283.00$236.2419.79%-1.30%
Aug 01, 2024David RodgersRobert W. Baird$287.00$237.8820.65%0.09%
May 29, 2024David RodgersRobert W. Baird$280.00$216.2129.50%-2.35%
Apr 05, 2024David RodgersRobert W. Baird$275.00$242.0413.62%-4.09%
Apr 04, 2024David ToungArgus Research$270.00$245.809.85%-5.84%
May 03, 2023Ann HynesMizuho Securities$174.00$166.874.27%-39.32%
Jan 12, 2023Argus Research$190.00$164.8315.27%-33.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 04, 2024Bank of America SecuritiesNeutralNeutralhold
Sep 18, 2024CitigroupBuyBuyhold
Sep 06, 2024Wells FargoEqual-WeightEqual-Weighthold
Aug 26, 2024Cowen & Co.BuyBuyhold
Aug 21, 2024Leerink PartnersUnderperformUnderperformhold
Aug 01, 2024Wells FargoEqual-WeightEqual-Weighthold
Jul 19, 2024CitigroupBuyBuyhold
Jul 09, 2024Leerink PartnersBuyBuyhold
Apr 29, 2024CitigroupBuyBuyhold
Dec 14, 2023CFRABuyupgrade

Financial Forecast

EPS Forecast

$-20 $-11 $-2 $7 $16 $25 Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$-16.65$7.48$8.15$8.62$7.60-----
Avg Forecast$7.87$9.23$2.78$11.93$13.65$15.16$16.59$18.15$20.68$22.96
High Forecast$8.07$9.47$3.33$11.95$13.67$15.46$17.17$20.01$21.30$23.65
Low Forecast$7.49$8.79$2.23$11.90$13.60$14.89$16.13$16.40$20.26$22.49
Surprise %-311.56%-18.96%193.17%-27.75%-44.32%-----

Revenue Forecast

$0 $100B $200B $300B $400B $500B Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$189.89B$213.99B$238.59B$262.17B$293.96B-----
Avg Forecast$188.71B$212.20B$708.52M$259.67B$292.54B$320.22B$340.96B$363.69B$404.37B$443.83B
High Forecast$192.40B$216.34B$850.22M$261.65B$293.25B$324.52B$348.77B$364.51B$413.74B$454.12B
Low Forecast$181.71B$204.32B$566.81M$257.87B$291.78B$316.92B$334.75B$362.87B$398.07B$436.91B
Surprise %0.62%0.84%33574.22%0.96%0.49%-----

Net Income Forecast

$-4B $-2B $-100M $2B $3B $5B Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$-3.41B$1.54B$1.70B$1.75B$1.51B-----
Avg Forecast$69.98M$82.85M$91.14M$1.87B$2.73B$3.04B$3.33B$3.65B$4.14B$4.60B
High Forecast$83.98M$99.43M$109.37M$2.24B$2.74B$3.10B$3.44B$4.01B$4.27B$4.74B
Low Forecast$55.99M$66.28M$72.91M$1.49B$2.72B$2.98B$3.23B$3.28B$4.06B$4.51B
Surprise %-4970.64%1758.59%1763.96%-6.52%-44.74%-----

COR Forecast FAQ

Is Cencora stock a buy?

Cencora stock has a consensus rating of Buy, based on 39 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cencora is a favorable investment for most analysts.

What is Cencora's price target?

Cencora's price target, set by 39 Wall Street analysts, averages $288 over the next 12 months. The price target range spans from $288 at the low end to $288 at the high end, suggesting a potential 0.44% change from the previous closing price of $286.74.

How does Cencora stock forecast compare to its benchmarks?

Cencora's stock forecast shows a 0.44% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the medical distribution stocks industry (6.26%).

What is the breakdown of analyst ratings for Cencora over the past three months?

  • April 2025: 5.88% Strong Buy, 52.94% Buy, 35.29% Hold, 0% Sell, 5.88% Strong Sell.
  • March 2025: 5.88% Strong Buy, 52.94% Buy, 41.18% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 5.88% Strong Buy, 52.94% Buy, 35.29% Hold, 0% Sell, 5.88% Strong Sell.

What is Cencora’s EPS forecast?

Cencora's average annual EPS forecast for its fiscal year ending in September 2025 is $15.16, marking a 99.47% increase from the reported $7.6 in 2024. Estimates for the following years are $16.59 in 2026, $18.15 in 2027, $20.68 in 2028, and $22.96 in 2029.

What is Cencora’s revenue forecast?

Cencora's average annual revenue forecast for its fiscal year ending in September 2025 is $320.22B, reflecting a 8.93% increase from the reported $293.96B in 2024. The forecast for 2026 is $340.96B, followed by $363.69B for 2027, $404.37B for 2028, and $443.83B for 2029.

What is Cencora’s net income forecast?

Cencora's net income forecast for the fiscal year ending in September 2025 stands at $3.04B, representing an 101.36% increase from the reported $1.51B in 2024. Projections indicate $3.33B in 2026, $3.65B in 2027, $4.14B in 2028, and $4.6B in 2029.